Diagnostic and prognostic value of soluble mesothelin-related proteins in patients with malignant pleural mesothelioma in comparison with benign asbestosis and lung cancer
about
Serum mesothelin for diagnosing malignant pleural mesothelioma: an individual patient data meta-analysisBiomarkers and prognostic factors for mesotheliomaCurrent issues in malignant pleural mesothelioma evaluation and managementGuidelines for the diagnosis and treatment of malignant pleural mesotheliomaLatest developments in our understanding of the pathogenesis of mesothelioma and the design of targeted therapiesThe relationship between tumor MSLN methylation and serum mesothelin (SMRP) in mesothelioma.Soluble mesothelin-related protein in pleural effusion from patients with malignant pleural mesotheliomaMidkine is a potential novel marker for malignant mesothelioma with different prognostic and diagnostic values from mesothelinA proteomics-based approach identifies secreted protein acidic and rich in cysteine as a prognostic biomarker in malignant pleural mesothelioma.HMGB1 and Its Hyperacetylated Isoform are Sensitive and Specific Serum Biomarkers to Detect Asbestos Exposure and to Identify Mesothelioma Patients.Unusual presentation and location pleural malignant mesothelioma.Future developments in the management of malignant pleural mesothelioma.Diagnostic values of soluble mesothelin-related peptides for malignant pleural mesothelioma: updated meta-analysis.Glycodelin is a potential novel follow-up biomarker for malignant pleural mesothelioma.Prognostic value of several biomarkers for the patients with malignant pleural mesothelioma.Prognostication and monitoring of mesothelioma using biomarkers: a systematic review.Diagnosis and prognosis-review of biomarkers for mesothelioma.Plasma Biomarker Enrichment of Clinical Prognostic Indices in Malignant Pleural Mesothelioma.Prognostic significance of soluble mesothelin in malignant pleural mesothelioma: a meta-analysis.Biomarkers for early diagnosis of malignant mesothelioma: Do we need another moonshot?Combined serum mesothelin and carcinoembryonic antigen measurement in the diagnosis of malignant mesothelioma.Malignant Mesothelioma, BAP1 Immunohistochemistry, and VEGFA: Does BAP1 Have Potential for Early Diagnosis and Assessment of Prognosis?Serum soluble mesothelin-related peptide (SMRP): a potential diagnostic and monitoring marker for epithelial ovarian cancer.Evaluation of soluble mesothelin-related peptide as a diagnostic marker of malignant pleural mesothelioma effusions: its contribution to cytology.Changes of mesothelin and osteopontin levels over time in formerly asbestos-exposed power industry workers.Overexpressed genes in malignant pleural mesothelioma: implications in clinical management.Biomarkers for Early Diagnosis and Prognosis of Malignant Pleural Mesothelioma: The Quest Goes on.Breath analysis as a diagnostic and screening tool for malignant pleural mesothelioma: a systematic review
P2860
Q26860736-197749D0-B4B5-4878-94AD-913464CE6205Q28387194-57FD92DD-10B0-4713-BC4F-10C7BFB0A80AQ28393560-D2BEED5C-6A4B-43E7-ADCD-9F02F8C57EE4Q28394028-F83245A5-53D1-4021-8932-04267733F91BQ28395597-1874AC01-DC96-4D30-907C-320865115115Q35558563-2B22C070-70CC-44AB-88D7-1BA7DC092908Q36244087-0D1ED5A8-E6FF-4E5C-AAA5-EDCE7566F2E1Q36320997-41427FD3-7F81-476A-8554-C883EF643443Q36662001-3A112E54-2020-4B49-8FD9-B1262FA69E7EQ36901529-1C1EDA02-D955-452C-9CED-5ADB2E706FA1Q36986796-835F795F-2F84-4424-9968-C68E1A556555Q37449036-93A51845-329E-4168-963A-5C06A4878038Q37612152-96609E57-0B65-4A75-9680-3F30A9AA5392Q37687605-E933DA24-7366-440C-A3B7-40D2CC76CF19Q38585167-115EF5BB-150D-4025-B048-8E1DEA3E456DQ39124644-4717FC25-6606-4B98-915B-45F5111EE37FQ39434249-B34E3491-38E9-4001-AC81-40AC1D928E87Q39977787-379EC392-DD28-4FC7-ABD8-BA3E25585FBFQ41234207-8E83EDCD-B8A8-49BE-AA9C-613942CAD784Q41593380-277ADF1F-3B07-4BD1-9D40-B8F7AD75BB2FQ41920935-7F8E7224-44B5-47A6-B00C-1D0AFE998204Q42728294-EEBE37A9-300A-46B2-AACF-169380F42D4BQ43799326-61954851-7902-4146-A1FB-C2B05A5497E2Q46122543-6A5F8B12-4DB2-4C20-A11B-D5909645C4F8Q51206145-483B60DF-F0FE-4FCE-95B3-8DB7F96B8247Q52672878-2159FB43-3C43-4026-80D7-4AC90CB9C86CQ55459882-EA158DC5-58C6-47D3-9B90-B71076D6D0B8Q59132474-28235E7A-6970-401E-91B7-72661E2C3947
P2860
Diagnostic and prognostic value of soluble mesothelin-related proteins in patients with malignant pleural mesothelioma in comparison with benign asbestosis and lung cancer
description
2008 nî lūn-bûn
@nan
2008 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Diagnostic and prognostic valu ...... ign asbestosis and lung cancer
@ast
Diagnostic and prognostic valu ...... ign asbestosis and lung cancer
@en
Diagnostic and prognostic valu ...... ign asbestosis and lung cancer
@nl
type
label
Diagnostic and prognostic valu ...... ign asbestosis and lung cancer
@ast
Diagnostic and prognostic valu ...... ign asbestosis and lung cancer
@en
Diagnostic and prognostic valu ...... ign asbestosis and lung cancer
@nl
prefLabel
Diagnostic and prognostic valu ...... ign asbestosis and lung cancer
@ast
Diagnostic and prognostic valu ...... ign asbestosis and lung cancer
@en
Diagnostic and prognostic valu ...... ign asbestosis and lung cancer
@nl
P2093
P1476
Diagnostic and prognostic valu ...... ign asbestosis and lung cancer
@en
P2093
Felix J F Herth
Hans Hoffmann
Hendrik Dienemann
Joachim Schneider
Michael Meister
Thomas Muley
P304
P356
10.1097/JTO.0B013E318187491C
P407
P577
2008-11-01T00:00:00Z